<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://ipharmag.com/article/semaglutide-glp-1-ischemic-optic-neuropathy-vision-loss-study</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T04:37:28+00:00</news:publication_date>
      <news:title>GLP-1 Drugs Linked to a Small but Real Risk of Sudden Vision Loss in a Large US Study</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/glp-1-side-effects-explained-how-long-they-last</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T04:37:28+00:00</news:publication_date>
      <news:title>GLP-1 Side Effects Explained: What’s Common, What’s Serious and How Long They Last</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://ipharmag.com/article/arrowhead-aro-mapt-rnai-tau-alzheimers-early-data</loc>
    <news:news>
      <news:publication>
        <news:name>iPharmag</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-18T04:37:28+00:00</news:publication_date>
      <news:title>An RNA Drug Injected Under the Skin Cut Brain Tau by Up to 85% in an Early Alzheimer’s Trial</news:title>
    </news:news>
  </url>
</urlset>
